, Tracking Stock Market Picks
Enter Symbol:

down 23.92 %

ONCOTHYREON (ONTY) rated Buy with price target $10 by Stifel Nicolaus

Posted on: Friday,  Aug 24, 2012  8:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy ONCOTHYREON (NASDAQ: ONTY) on 08/24/2012, when the stock price was $4.64. Since
then, ONCOTHYREON has lost 23.92% as of 01/14/2016's recent price of $3.53.
If you would have followed this Stifel Nicolaus's recommendation on ONTY, you would have lost 23.92% of your investment in 1238 days.

Oncothyreon Inc. (Oncothyreon) is a clinical-stage biopharmaceutical company. The Company focuses primarily on the development of therapeutic products for the treatment of cancer. The Company?s cancer vaccines are designed to stimulate the immune system to attack cancer cells, while its small molecule compounds are designed to inhibit the activity of specific cancer-related proteins. Oncothyreon?s lead product candidate is Stimuvax, which is a cancer vaccine in Phase III development for non-small cell lung cancer (NSCLC). Oncothyreon has an exclusive, worldwide license to Merck KGaA of Darmstadt, Germany (Merck KGaA), for the development, manufacture and commercialization of Stimuvax. Its pipeline of product candidates is consisted of cancer vaccines and small molecule candidates. The Company?s wholly owned subsidiaries include Oncothyreon Canada Inc., Biomira Management Inc., ProlX Pharmaceuticals Corporation, Biomira International Inc., Biomira BV and Oncothyreon Luxembourg.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/24/2012 8:25 AM Buy
4.64 10.00
as of 12/31/2012
1 Week up  1.58 %
1 Month down  -58.07 %
3 Months down  -62.57 %
1 YTD down  -58.62 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy